OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
63 hedge funds and large institutions have $155M invested in OncoMed Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
23% less capital invested
Capital invested by funds: $200M → $155M (-$45.3M)
Holders
63
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$15.3M | |
| 2 | +$3.96M | |
| 3 | +$2.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.1M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.75M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$4.33M | |
| 3 | -$3.82M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$1.73M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.68M |